Literature DB >> 26377331

Androgen levels and apoptosis in the testis during postnatal development of finasteride-treated male rat offspring.

Agnieszka Kolasa-Wolosiuk1, Kamila Misiakiewicz-Has, Irena Baranowska-Bosiacka, Izabela Gutowska, Barbara Wiszniewska.   

Abstract

INTRODUCTION: The hormone-dependent events that occur throughout the first wave of spermatogenesis, such as the establishment of the number of Sertoli cells (SCs) and spermatogonial stem cells (SSCs) within the seminiferous cords and the setting up of the blood-testis barrier, are important for adult male fertility. Any changes in the T/DHT ratio can result in male subfertility or even infertility. In this study we aimed to evaluate effects of paternal exposure to 5-alpha reductase type 2 inhibitor, finasteride on litter size, androgen levels and germ cell apoptosis in male offspring during postnatal development.
MATERIAL AND METHODS: The subjects of the study were 7, 14, 21/22, 28, and 90-day-old Wistar male rats (F1:Fin) born from females fertilized by finasteride-treated rats. Offspring born from untreated parental animals were used as a control group (F1:Control). Animals and the collected testes were weighed, blood and intratesticular levels of T and DHT were measured by ELISA, and the apoptotic index of testicular cells was evaluated by TUNEL technique.
RESULTS: We observed difficulties in obtaining male newborns from female rats fertilized by finasteride-treated male rats. In the F1:Fin rats, changes in the body and testes weights occurred, and a lower number of apoptotic cells was found during postnatal maturation of the seminiferous epithelium. Changes in androgen concentrations during the first spermatogenesis wave and adult life were also evident.
CONCLUSION: Finasteride treatment of male adult rats may not only cause a decrease in the fertility of parental rats, but also could lead to incorrect, androgen-sensitive course of spermatogenesis in their offspring.

Entities:  

Keywords:  TUNEL; finasteride treatment; germ-cell apoptosis; male rats; offspring androgen levels

Mesh:

Substances:

Year:  2015        PMID: 26377331     DOI: 10.5603/fhc.a2015.0025

Source DB:  PubMed          Journal:  Folia Histochem Cytobiol        ISSN: 0239-8508            Impact factor:   1.698


  6 in total

1.  Paternal Finasteride Treatment Can Influence the Testicular Transcriptome Profile of Male Offspring-Preliminary Study.

Authors:  Agnieszka Kolasa; Dorota Rogińska; Sylwia Rzeszotek; Bogusław Machaliński; Barbara Wiszniewska
Journal:  Curr Issues Mol Biol       Date:  2021-07-31       Impact factor: 2.976

2.  Antioxidant enzyme expression of mRNA and protein in the epididymis of finasteride-treated male rat offspring during postnatal development.

Authors:  Agnieszka Kolasa-Wołosiuk; Maciej Tarnowski; Irena Baranowska-Bosiacka; Dariusz Chlubek; Barbara Wiszniewska
Journal:  Arch Med Sci       Date:  2017-08-03       Impact factor: 3.318

3.  Finasteride-Induced Inhibition of 5α-Reductase Type 2 Could Lead to Kidney Damage-Animal, Experimental Study.

Authors:  Mirza Saim Baig; Agnieszka Kolasa-Wołosiuk; Anna Pilutin; Krzysztof Safranow; Irena Baranowska-Bosiacka; Joanna Kabat-Koperska; Barbara Wiszniewska
Journal:  Int J Environ Res Public Health       Date:  2019-05-16       Impact factor: 3.390

4.  Connexin 43 expression in the testes during postnatal development of finasteride-treated male rat offspring.

Authors:  Agnieszka Kolasa-Wołosiuk; Kamila Misiakiewicz-Has; Irena Baranowska-Bosiacka; Izabela Gutowska; Maciej Tarnowski; Marta Tkacz; Barbara Wiszniewska
Journal:  Arch Med Sci       Date:  2016-11-15       Impact factor: 3.318

5.  Effect of finasteride particle size reduction on its pharmacokinetic, tissue distribution and cellular permeation.

Authors:  Tarek A Ahmed; Ahmed M Al-Abd
Journal:  Drug Deliv       Date:  2018-11       Impact factor: 6.419

6.  Mapping the past, present and future research landscape of paternal effects.

Authors:  Joanna Rutkowska; Malgorzata Lagisz; Russell Bonduriansky; Shinichi Nakagawa
Journal:  BMC Biol       Date:  2020-11-27       Impact factor: 7.431

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.